skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 2
Patent #:
Issue Dt:
03/01/2016
Application #:
13992053
Filing Dt:
06/06/2013
Publication #:
Pub Dt:
09/26/2013
PCT #:
US1163465
Inventors:
Thomas Jon Seiders, Bowei Wang, John Howard Hutchinson, Nicholas Simon Stock et al
Title:
LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AND THEIR USE IN THE TREATMENT FIBROSIS
Assignment: 1
Reel/Frame:
027998/0719Recorded: 04/05/2012Pages: 8
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
01/23/2012
Exec Dt:
02/16/2012
Exec Dt:
01/11/2012
Exec Dt:
01/12/2012
Exec Dt:
02/20/2012
Assignee:
ROUTE 206 & PROVINCE LINE ROAD
PATENT DEPARTMENT
PRINCETON, NEW JERSEY 08543-4000
Correspondent:
MAUREEN S. GIBBONS
ROUTE 206 & PROVINCE LINE ROAD
PATENT DEPARTMENT
PRINCETON, NJ 08543-4000
Assignment: 2
Reel/Frame:
030498/0470Recorded: 05/28/2013Pages: 10
Conveyance:
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNEE ON PAGE 1, PARAGRAPH 2 TO AMIRA PHARMACEUTICALS, INC. PREVIOUSLY RECORDED ON REEL 027998 FRAME 0719. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECTION TO AMIRA PHARMACEUTICALS, INC.
Assignors:
Exec Dt:
01/23/2012
Exec Dt:
02/16/2012
Exec Dt:
01/11/2012
Exec Dt:
01/12/2012
Exec Dt:
02/20/2012
Assignee:
ROUTE 206 & PROVINCE LINE ROAD
PATENT DEPARTMENT
PRINCETON, NEW JERSEY 08543-4000
Correspondent:
MAUREEN S. GIBBONS
ROUTE 206 & PROVINCE LINE ROAD
PATENT DEPARTMENT
PRINCETON, NJ 08543-4000

Search Results as of: 06/20/2024 10:36 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT